Corteva Raises Full-Year Outlook Amid Strong First-Half Performance
Corteva (NYSE:CTVA) raised its full-year outlook following strong performance in the first half of 2026. The company now expects operating EBITDA to range between $4.1 billion and $4.3 billion, with operating EPS projected at $3.60–$3.80 per share. First-half sales rose by 4% year-over-year to $11.3 billion, while EBITDA increased by 10% to $3.7 billion. The growth was driven by strong seed demand, licensing income, new crop-protection products, and cost savings that offset pricing pressure in Brazil. Corteva remains on track for its business separation scheduled for October 1, with the advanced seed and genetics company set to operate as Vylor. Management expects low-double-digit growth in seed sales and high-single-digit volume growth in crop protection during the second half of the year. The firm also anticipates significantly lower dis-synergies from the separation than previously estimated. Despite a projected flat EBITDA performance for the back half, Corteva is forecasting strong fourth-quarter earnings due to favorable factors such as price and mix benefits, cost efficiencies, currency gains, and improved seed royalties.
Tickers: $CTVA